DILIC
ACAD icon

Dai-ichi Life Insurance Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-41,039
Closed -$1.55M – 504
2017
Q3 		$1.55M Sell
41,039
-1,604
-4% -$52.2K 0.03% 338
2017
Q2 		$1.19M Sell
42,643
-59,354
-58% -$1.77M 0.03% 369
2017
Q1 		$3.51M Buy
+101,997
New +$3.6M 0.1% 226

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dai-ichi Life Insurance Company's ACAD Position: Q4 2017 in Review

Dai-ichi Life Insurance Company sold out of Acadia Pharmaceuticals (ACAD) in Q4 2017, closing a stake of 41,039 shares — an estimated $1.55M sold.

Dai-ichi Life Insurance Company first reported a position in ACAD in Q1 2017 and held it in 3 quarters. The position peaked at $3.51M in Q1 2017. 210 funds tracked by Wall St. Rank hold ACAD as of Q4 2017.

  • Dai-ichi Life Insurance Company reported no remaining Acadia Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 41,039 Acadia Pharmaceuticals shares in Q4 2017, an estimated $1.55M.
  • Dai-ichi Life Insurance Company first reported a position in Acadia Pharmaceuticals in Q1 2017 and held it in 3 quarters.
  • Dai-ichi Life Insurance Company's Acadia Pharmaceuticals position peaked at $3.51M in Q1 2017.
  • 210 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2017.

Based on Dai-ichi Life Insurance Company's 13F filing for Q4 2017, filed 13 Feb 2018.